Oncology News

Incidence of hepatocellular carcinoma was significantly higher among cirrhotic patients coinfected with hepatitis B and D viruses compared with those with HBV alone, with researchers suggesting HDV “plays a direct role” in HCC occurrence.

In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses areas of research that need to be explored in treating cholangiocarcinoma.

In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses the latest developments in targeted therapy options for cholangiocarcinoma.

In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses the impact of sequencing targeted therapies when treating patients with cholangiocarcinoma.

In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses the challenges in treating patients with cholangiocarcinoma.

SAN DIEGO — Liver stiffness measurements may help predict the risk for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease, as well as identify those in need of surveillance, according to data.

Survival for people with hepatocellular carcinoma has improved over the last decade, according to study results.

Patients who tested positive for hepatitis D virus antibodies were at greater risk for developing hepatocellular carcinoma and other adverse liver-related outcomes, often at a young age, according to study results.

Every October marks Liver Cancer Awareness Month in an effort to raise awareness and improve advocacy and treatment for patients living with the disease.